Company to Provide Starting 2027 Growth Framework on Earnings Conference CallThird Quarter 2026 HighlightsTotal reported revenue of $1.767 billion exceeded guidance midpoint by $14 million, led by organic revenue growth
Adds MOBILion's breakthrough SLIM high-resolution ion mobility technology, which separates molecules by size, shape and charge in milliseconds, complementing Waters' industry leading mass spectrometry platform,
Advances Waters' strategy to bring trusted AI, ML, and automation capabilities to the 500,000 Empower™ Software users who run the world's regulated chromatography labs and support the release of over 80% of
Labcorp intends to be the first commercial laboratory to offer FDA-approved HPV testing with the BD Onclarity™ HPV Assay across clinician-collected and self-collected screening options in clinic, patient service center,
Expands access to most comprehensive FDA-approved HPV test and at-home self-collection option across Quest's national clinician, health plan, and consumer channels starting in 2027First and only FDA-approved HPV
IMU is collaborating with UK Biobank, Waters Corporation and Ultima Genomics to profile blood samples from an initial cohort of 80,000 UK Biobank blood samples
IMU will generate more than 100 million immune data
Accelerates research and development by enabling AI-augmented workflows and automated lab-in-the-loop cycles, already a new and fast-growing source of demand for Waters' instruments and consumablesLeverages
MILFORD, Mass., Oct. 1, 2026 /PRNewswire/ -- Waters Corporation (NYSE:WAT) will hold its Q3 2026 financial results conference call on Tuesday, November 3, 2026, at 8:00 a.m. Eastern Time. A live webcast of the
Enables routine 50+ parameter experiments with BD SpectralFX™ Technology, accelerating breakthrough discoveries in the fight against cancer and other diseases.Minimizes instrument and user differences with
MILFORD, Mass., Sept. 11, 2026 /PRNewswire/ -- Waters Corporation (NYSE:WAT) announced that Udit Batra, Ph.D., Waters President and Chief Executive Officer, will participate in a fireside chat at the J.P. Morgan U.S.
MILFORD, Mass., Aug. 26, 2026 /PRNewswire/ -- Waters Corporation (NYSE:WAT) announced that Udit Batra, Ph.D., Waters President and Chief Executive Officer, will participate in a fireside chat at the Wells Fargo
Second Quarter 2026 HighlightsTotal reported revenue of $1.645 billion surpassed the high end of the guidance range, driven by broad-based outperformance across both organic revenue and the acquired businesses.Organic
Brings Xevo™ TQ Absolute XR Mass Spectrometer's industry-leading tandem quadrupole MS sensitivity to clinical applications across women's health, cancer assessment, and toxicology.Offers 5x greater sensitivity
MILFORD, Mass., July 2, 2026 /PRNewswire/ -- Waters Corporation (NYSE:WAT) will hold its Q2 2026 financial results conference call on Tuesday, August 4, 2026, at 8:00 a.m. Eastern Time. A live webcast of the
IMU’s AI platform unlocks unprecedented immune insights for cancer and other diseases, measuring 100M+ data points from a single blood sample, analyzed in real time.Waters Biosciences’ technologies, including BD
